entertainment -WSS

entertainment

author：comprehensive 2025-08-12 06:43:24 - browse：8768

A nurse prepares to administer chemotherapy treatment. -- Cancer coverage from STAT — Preparing a chemotherapy treatment at Duke Cancer Center in Durham, N.C. Gerry Broome/AP

A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic with acute lymphoblastic leukemia, the most common of all childhood cancers. One of the drugs needed for treatment was methotrexate. The only problem was that the drug was in short supply.

“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”

Methotrexate isn’t the only essential chemotherapy clinicians are having a hard time getting their hands on right now. Two other key chemotherapies, cisplatin and carboplatin, which are also generic injectable drugs, have been in shortage for the last few months. But Unguru didn’t see this particular patient recently or even in the last year. He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Breakthrough Alzheimer’s drugs are inaccessible in rural states

leisure time

WSS

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Hospitals struggle to profit from CAR

Divers poised to search for children washed away in Pennsylvania flash flood

NIH launches clinical trials and new research office for long Covid

I learned firsthand about improving diversity in clinical trials

hotspot

entertainment

focus

The high cost of giving birth even with insurance

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Bright Health sells Medicare Advantage business to Molina

EQRx, failed developer of low

Medicare details structure of new drug price negotiation program

Wildfire pollution widens asthma inequities on Long Island

How to save PrEP access — and even expand it

Mass General totes up its waste in a move to tackle climate change

Guidelines to prevent youth baseball injuries need more muscle

Indian pharmaceutical industry in denial over drug

leisure time

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Micronoma's microbiome cancer diagnostic approach under fire

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Tesla recalling nearly 16,000 of its 2021

Vir antibody drug aimed at influenza A fails in clinical trial

Hospitals struggle to profit from CAR

leisure time

focus

entertainment

explore